These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25858863)

  • 1. Distribution of lymphocyte subpopulations in patients with polycythemia vera.
    Sanchez C; Le Treut T; Baier C; Sébahoun G; Costello RT
    Hum Immunol; 2015 Jun; 76(6):414-6. PubMed ID: 25858863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells in patients with polycythemia vera.
    Sanchez C; Baier C; Colle JG; Chelbi R; Rihet P; Le Treut T; Imbert J; Sébahoun G; Venton G; Costello RT
    Hum Immunol; 2015 Sep; 76(9):644-50. PubMed ID: 26407910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
    Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
    Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.
    Riley CH; Brimnes MK; Hansen M; Jensen MK; Hasselbalch HC; Kjaer L; Straten PT; Svane IM
    Eur J Haematol; 2016 Jul; 97(1):83-92. PubMed ID: 26385526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.
    Carbone J; Gallego A; Lanio N; Navarro J; Orera M; Aguaron A; Fernandez-Cruz E; Sarmiento E
    J Rheumatol; 2009 Jun; 36(6):1217-25. PubMed ID: 19332638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Janus associated kinase 2 (V617F) mutation in patients of polycythemia vera.
    Khattak SA; Ahmed S; Anwar J; Bozdar M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):80-3. PubMed ID: 22313642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive CD8
    Cardoso EM; Esgalhado AJ; Patrão L; Santos M; Neves VP; Martinez J; Patto MAV; Silva H; Arosa FA
    Ann Hematol; 2018 Sep; 97(9):1563-1575. PubMed ID: 29789880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
    Rossi D; Cortini F; Deambrogi C; Barbieri C; Cerri M; Franceschetti S; Conconi A; Capello D; Gaidano G
    Leuk Res; 2007 Jan; 31(1):97-101. PubMed ID: 16620973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The feature of T cell clonality with polycythemia vera].
    Li Y; Yang L; Chen S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):570-2. PubMed ID: 11721372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.
    Agrati C; Nisii C; Oliva A; D'Offizi G; Montesano C; Pucillo LP; Poccia F
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):307-16. PubMed ID: 12455864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosis.
    Fleischman RA
    Am J Med Sci; 2013 Oct; 346(4):328-30. PubMed ID: 23588264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis.
    Skov V; Thomassen M; Riley CH; Jensen MK; Bjerrum OW; Kruse TA; Hasselbalch HC; Larsen TS
    Exp Hematol; 2012 Sep; 40(9):771-780.e19. PubMed ID: 22659388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
    Cornfield DB; Gheith SM
    Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
    Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polycythemia vera and JAK-2 mutation in childhood: a case report].
    Braconnier O; Monpoux F; Affanetti M; Bérard E; Sirvent N
    Arch Pediatr; 2007 Oct; 14(10):1202-5. PubMed ID: 17693067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.
    Gangemi S; Allegra A; Pace E; Alonci A; Ferraro M; Petrungaro A; Saitta S; Gerace D; Russo S; Penna G; Musolino C
    Cell Immunol; 2012; 278(1-2):91-4. PubMed ID: 23121980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric analysis of lymphocyte subsets in patients with advanced periodontitis.
    Zafiropoulos GG; Flores-de-Jacoby L; Schoop B; Havemann K; Heymanns J
    J Clin Periodontol; 1990 Oct; 17(9):636-41. PubMed ID: 2147440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.